Interview with Denisa Timkova, General Manager, Cegedim Hungary
Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…
Address: Krisztina krt. 39/b H-1013 Budapest,Hungary
Tel: +36 1 487 3100
Web: http://www.cegedim.com/Pages/default.aspx
Founded in 1969, Cegedim is an innovation-led global technology and services company specializing
in the healthcare field.
Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life
Cegedim supplies services, technological tools, specialized software, data flow management services and databases
Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies.
The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data.
Cegedim employs 8,500 people in more than 80 countries and generated revenue of €927 million in 2010.
The Cegedim Group’s services have strong synergies that are combined in three sectors of activity.
1.CRM and strategic data
CRM, compliance and marketing solutions, databases, market research studies… for the life sciences industry.
2.Healthcare professionnals
Software publishing, healthcare networks, promotional information… dedicated to doctors, pharmacists and paramedics
3.Insurances and services
IT for healthcare insurers, data flow management, outsourced solutions… for companies of all sectors
Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…
The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of Prime Minister…
Dr. Zsuzsanna Fürst, President of the Ethics Committee for Clinical Pharmacology, elaborates on the role and activities of the ethics committee, shares her insights on structural framework of the application…
Dr Beata Sperlagh, Deputy Director of the Institute of Experimental Medicine (IEM), shares her insights on the institute’s involvement in research and with the private sector, the key strengths of…
Irisz Lippai-Nagy, CEO of AmCham Hungary, shares insights on the drivers contributing to economic growth in Hungary, recent policies and reforms, the role of the association, and policy recommendations to…
Oliver Strommer, newly appointed executive director of the British Chamber of Commerce in Hungary (BCCH), introduces the Chamber and its refocused aim of becoming a more dynamic player in business…
Investments in research and development are on the rise in Hungary, backed up by government initiatives, but the country needs a more unified effort between the public and private sectors…
Hungary’s two largest pharma firms, Egis Pharmaceuticals and Gedeon Richter, are stepping up their biosimilars offering; providing the European market with more affordable biologic medicines and bolstering Hungary’s footprint in…
Like many of its European counterparts, Hungary is suffering from medicine shortages. Vaccines, vitamins, and orphan drugs are some of the most affected areas and oncology patients are now also…
Hungarian patients currently experience longer wait times and more limited access to subsidised innovative medicines than their neighbours in Bulgaria and Slovakia.leading some organisations to urge the government to increase…
Hungary’s Minister of Finance Mihály Varga has repeatedly underlined the importance of the pharmaceutical industry to the country’s economy in recent weeks. With this strong governmental backing, pharma stands to…
Hungary has long been one of the leading countries in Central and Eastern Europe for clinical trials. However, a downward trend in the number of research projects being conducted in…
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The country’s innovative pharma association has taken the initiative to suggest measures that…
See our Cookie Privacy Policy Here